Boston Scientific Challenges Johnson & Johnson’s Leadership in US Electrophysiology Market

In a significant shift within the US electrophysiology device market, Boston Scientific is mounting a serious challenge to Johnson & Johnson’s longstanding dominance. With Boston Scientific’s Farawave pulsed field ablation catheter achieving substantial market success, the company is poised to intensify competition and potentially alter the industry landscape. 

For over a decade, Johnson & Johnson has comfortably held the largest share of the US electrophysiology device market. However, recent data from GlobalData indicates a rising tide for Boston Scientific, thanks to its highly successful Farawave catheter, which has quickly become the top revenue-generating product since its 2024 approval. Currently, Boston Scientific sits in second place, with prospects of matching or surpassing Johnson & Johnson’s 40% market share. This rivalry could redefine competitive strategies, as both companies have similar pricing structures, pushing them to differentiate through innovation and other non-price factors. Meanwhile, Medtronic is also improving its standing, approaching Abbott for the third spot, suggesting ongoing turbulence in market rankings.